← Leaderboards
Siddhartha Na Das
University Of Texas El Paso
$3,015,279
Attributed
$3,231,629
Total exposure
10
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $466.6K · FY2005–19$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$3,231,629 · 10
By mechanism
R01$2,084,037 · 1
S06$487,248 · 1
R21$432,700 · 1
G12$227,644 · 7
Top collaborators
- Steven E Patterson2 shared
Others in their field
Top investigators on “Glucosylceramides”
- Besim Ogretmen · Medical University Of South Carolina$7,165,601
- Maurizio Del Poeta · Northport Va Medical Center$5,863,642
- Gregory A. Grabowski · Children'S Hospital Med Ctr (Cincinnati)$5,794,250
- James Alan Shayman · University Of Michigan At Ann Arbor$5,313,749
- John H Griffin · Scripps Research Institute$4,621,751
- Leo J Pallanck · University Of Washington$4,390,295
Research focus
GlucosylceramidesCystTransferaseGiardia LambliaCellsParasitesGiardiaStomachWaterExcystationGenesProductionGastric AcidMolecularEnzymesBaseResistanceBiochemicalMetabolic PathwayPathway InteractionsBiogenesisDrug ResistanceLaboratoriesAnabolism
Grant awards (19)
Discovery of a novel target for giardiasis$190,700
R21 · FY2019 · AI
Discovery of a novel target for giardiasis$242,000
R21 · FY2018 · AI
Sphingolipid and Mechanism of Cyst Formation by Giardia$419,620
R01 · FY2015 · AI · contact PI
Sphingolipid and Mechanism of Cyst Formation by Giardia$419,620
R01 · FY2014 · AI · contact PI
Sphingolipid and Mechanism of Cyst Formation by Giardia$394,442
R01 · FY2013 · AI · contact PI
Sphingolipid and Mechanism of Cyst Formation by Giardia$424,308
R01 · FY2012 · AI · contact PI
Sphingolipid and Mechanism of Cyst Formation by Giardia$426,047
R01 · FY2011 · AI · contact PI
INFECTIOUS DISEASES AND IMMUNOLOGY PROJECT$40,540
G12 · FY2011 · RR · contact PI
Sphingolipids as Potential Targets for Anti-Giardial Therapy$115,055
S06 · FY2010 · GM · contact PI
INFECTIOUS DISEASES AND IMMUNOLOGY PROJECT$34,779
G12 · FY2010 · RR · contact PI
Sphingolipids as Potential Targets for Anti-Giardial Therapy$130,355
S06 · FY2009 · GM · contact PI
INFECTIOUS DISEASES$28,733
G12 · FY2009 · RR · contact PI
Sphingolipids as Potential Targets for Anti-Giardial Therapy$100,503
S06 · FY2008 · GM · contact PI
INFECTIOUS DISEASES$10,572
G12 · FY2008 · RR · contact PI
Sphingolipids as Potential Targets for Anti-Giardial Therapy$141,335
S06 · FY2007 · GM · contact PI
INFECTIOUS DISEASES$27,892
G12 · FY2007 · RR · contact PI
INFECTIOUS DISEASES$29,354
G12 · FY2006 · RR · contact PI
INFECTIOUS DISEASES$29,351
G12 · FY2005 · RR
INFECTIOUS DISEASES$26,423
G12 · FY2004 · RR